Search Count: 8
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.11 Å Release Date: 2024-09-04 Classification: ANTIVIRAL PROTEIN Ligands: K |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2024-09-04 Classification: ANTIVIRAL PROTEIN Ligands: K |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.54 Å Release Date: 2024-09-04 Classification: ANTIVIRAL PROTEIN Ligands: K |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2021-07-07 Classification: OXIDOREDUCTASE Ligands: KUK, PO4, NAD, MPD |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-07-07 Classification: OXIDOREDUCTASE Ligands: 9L9, PO4, NAD |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2021-07-07 Classification: OXIDOREDUCTASE Ligands: KUN, PO4, ADP, GOL |
 |
Hiv-1 Protease Inhibitors Containing A Tertiary Alcohol In The Transition-State Mimic With Improved Cell-Based Antiviral Activity
Organism: Human immunodeficiency virus type 1 (z2/cdc-z34 isolate)
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2009-12-15 Classification: HYDROLASE Ligands: 5AH |
 |
Hiv-1 Protease Inhibitors Containing A Tertiary Alcohol In The Transition-State Mimic With Improved Cell-Based Antiviral Activity
Organism: Human immunodeficiency virus type 1 (z2/cdc-z34 isolate)
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2009-12-15 Classification: HYDROLASE Ligands: 5AH |